Opaleye Management Inc.'s Form 4 filing
Protara Therapeutics, Inc. (TARA) · filed May 31, 2024
- Accession no.
- 0001493152-24-022195
- Filed
- May 31, 2024
- Trade date
- May 30-31, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $44.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −9,230 | $2.94F2 | −$27,136.2 | 114,520 | Indirect | |
| May 31, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −5,824 | $2.90F3 | −$16,889.6 | 108,696 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.90-$2.98 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.9007-$2.9011 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
Referenced by the price of 1 transaction in Table I.